Northeast Financial Consultants’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,006	Closed	-$239K	–	300
2024 Q3	$239K	Buy	2,006 +238	+13%	+$28.3K	0.01%	260
2024 Q2	$252K	Buy	+1,768	New	+$252K	0.01%	246